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CASE REPORTSTricuspid valve reconstruction with the extracellular matrix tube
technique: A word of cautionYoshiya Toyoda, MD, Mohammed A. Kashem, MD, Kazuhiro Hisamoto, MD, and Akira Shiose, MD,
Philadelphia, PaWe report a case in which a recently described surgical tech-
nique was used to reconstruct the entire tricuspid valve with
a CorMatrix extracellular matrix (ECM) tube (CorMatrix
Cardiovascular Inc, Roswell, Ga).1,2 The repair showed
initial success but ultimately failed.CLINICAL SUMMARY
A 34-year-old woman, a current user of intravenous
drugs, had development of tricuspid valve endocarditis
with vegetations and severe regurgitation, along with mul-
tiple abscesses in her lungs. The patient underwent
tricuspid valve surgery through a median sternotomy
with standard bicaval cardiopulmonary bypass. At surgery,
almost the entire tricuspid valve and the subvalvular appa-
ratus were seen to have been destroyed and replaced with
vegetations. The tricuspid annulus was measured at 50
mm. Two edges of a 10-cm CorMatrix ECM biomaterial
patch were sewn together with 5-0 Prolene suture (Ethicon
Inc, Somerville, NJ) in running fashion to create a tube 30
mm in diameter. Under aortic crossclamping, the entireFIGURE 1. A, Drawing of the surgical technique. B, Intraoperative photograp
matrix tube.
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valvular apparatus were resected. With CorMatrix ECM
used to form pledgets, a buttress stitch of 5-0 Prolene su-
ture was placed on each of 3 papillary muscles and
through the edge of the CorMatrix tube at 120 intervals
and tied down. The other end of the tube was sewn to
the tricuspid annulus of the anterior and posterior leaflet
insertions with 5-0 Prolene suture in running fashion.
The patch attached to the tube was trimmed to cover the
triangle of Koch and was sewn to the right atrial tissue
from the commissure between the posterior and septal
leaflets towards the inside of the coronary sinus, along
the tendon of Todaro, to the commissure between the ante-
rior and septal leaflets to avoid damaging the conduction
system (Figure 1, A). The leak test with saline injection re-
vealed a competent newly created tricuspid valve
(Figure 1, B). The aortic crossclamp time was 62 minutes.
The cardiopulmonary bypass time was 104 minutes. The
patient’s postoperative recovery was uneventful, with a
hospital stay of 7 days.
Transthoracic echocardiography before discharge
showed a well-functioning ECM tube as the new tricuspid
valve without stenosis or regurgitation (Figure 2); however,
the patient was readmitted in a few months. Echocardiogra-
phy showed tricuspid valve regurgitation, with the entire
CorMatrix tube prolapsing into the right atrium
(Figure 3). The CorMatrix tube was removed, and a
tricuspid valve replacement was performed with a porcine
valve. The CorMatrix tube was torn and had degenerative
changes (Figure 4). The pathology report showed tissue
with necrosis, fibrinopurulent debris, gram-positiveh of the newly reconstructed tricuspid valve with a CorMatrix extracellular
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FIGURE 2. Postoperative transthoracic echocardiography after tricuspid valve reconstruction with CorMatrix extracellular matrix. A, Systole without co-
lor. B, Systole with color. C, Diastole without color. D, Diastole with color.
Case Reportsbacterial colonies, and granulation tissue formation. The
patient’s recovery was uneventful, with a hospital stay of
10 days.FIGURE 3. Transesophageal echocardiography showing prolapse of the
entire CorMatrix extracellular matrix tube.
e142 The Journal of Thoracic and Cardiovascular SurDISCUSSION
Recently, a novel surgical technique was reported for
reconstruction of the entire tricuspid valve with a CorMa-
trix ECM tube.1,2 The long-term outcome, however, re-
mains unclear. We achieved an initial success with this
technique, but the repair failed in a few months. This in-
dicates that the tube technique works, but the material in
creating the tube is not good enough to provide durable
outcomes. CorMatrix ECM is produced from porcine
small intestinal submucosa. An acellular biomaterial
that contains primarily collagen, it has been used for
intracardiac repair.3 There are several benefits of using
this tube technique. First, complete resection of infected
tissue is possible, because any defect can be filled with
the ECM patch. Second, this technique eliminates need
for an annuloplasty ring, because the ECM tube itself
acts as in that capacity. Third, with our modified tech-
nique, the conduction system can be avoided because
the patch can be trimmed as needed to keep the suture
line away from the conduction system. Finally, with
this technique, the tricuspid annulopapillary musclegery c August 2014
FIGURE 4. Intraoperative photographs of the CorMatrix extracellular matrix tube at removal. A, Prolapsing CorMatrix tube. B, Resected CorMatrix tube
showing infection and degenerative changes.
Case Reportscontinuity is preserved.4 The failure that we observed in
this case may have been due to the weak antiinfective
property of CorMatrix or to its fragile nature when it is
in the body for certain duration. CorMatrix ECM’s resis-
tance to infection depends on angiogenesis and thus on
the patient’s own defense mechanisms. This may not be
adequate.
In conclusion, reconstruction of the entire tricuspid valve
with the ECM tube technique is efficacious in achieving
excellent valve function. The CorMatrix ECM, however,
may not be the ideal material to provide long-term durable
outcomes.From the Division of Cardiac Surgery,a Johns Hopkins University School of Medi-
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